Your browser doesn't support javascript.
loading
Perinatal Management for a Pregnant Woman with an MYH9 Disorder.
Yamashita, Yuka; Matsuura, Rei; Kunishima, Shinji; Oikawa, Yoshie; Ariizumi, Hirotsugu; Hamada, Shoko; Shirato, Nahoko; Matsuoka, Ryu; Ogawa, Kohichi; Sekizawa, Akihiko.
Afiliação
  • Yamashita Y; Department of Obstetrics and Gynecology, Showa University Fujigaoka Hospital, 1-30 Fujigaoka, Aoba-ku, Yokohama 227-8501, Japan.
  • Matsuura R; Department of Obstetrics and Gynecology, Showa University Fujigaoka Hospital, 1-30 Fujigaoka, Aoba-ku, Yokohama 227-8501, Japan.
  • Kunishima S; Department of Advanced Diagnosis, Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
  • Oikawa Y; Department of Clinical Laboratory, Showa University Fujigaoka Hospital, Yokohama, Japan.
  • Ariizumi H; Department of Hematology, Showa University Fujigaoka Hospital, Yokohama, Japan.
  • Hamada S; Department of Obstetrics and Gynecology, Showa University Fujigaoka Hospital, 1-30 Fujigaoka, Aoba-ku, Yokohama 227-8501, Japan.
  • Shirato N; Department of Obstetrics and Gynecology, Showa University School of Medicine, Tokyo, Japan.
  • Matsuoka R; Department of Obstetrics and Gynecology, Showa University School of Medicine, Tokyo, Japan.
  • Ogawa K; Department of Obstetrics and Gynecology, Showa University Fujigaoka Hospital, 1-30 Fujigaoka, Aoba-ku, Yokohama 227-8501, Japan.
  • Sekizawa A; Department of Obstetrics and Gynecology, Showa University School of Medicine, Tokyo, Japan.
Case Rep Obstet Gynecol ; 2016: 6730174, 2016.
Article em En | MEDLINE | ID: mdl-27437156
We diagnosed a primipara woman with an MYH9 disorder during her pregnancy. A peripheral blood smear with an immunofluorescence analysis is the established method of diagnosing MYH9 disorders. We provided genetic counseling, as required, which included apprising the woman of the inheritance pattern, the importance of a genetic analysis, and the potential delivery risks for the patient and her offspring. Given that the potential delivery risks are reportedly low, special perinatal management is not necessary for patients with an MYH9 disorder whose platelet count is above 5.0 × 10(4)/µL, except for rapid blood access.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2016 Tipo de documento: Article